Generic Tagrisso (Osimertinib)

What is Tagrisso (Osimertinib)?

Tagrisso® is the originator brand name for osimertinib, developed by AstraZeneca. It is a targeted oncology therapy prescribed in the management of EGFR-mutation-positive non-small cell lung cancer, including tumours carrying the T790M resistance mutation. As a prescription-only medicine, it is used under the supervision of a qualified oncologist who will confirm that your tumour carries a relevant EGFR mutation before treatment.

How Osimertinib works

Osimertinib belongs to a class of medicines called tyrosine kinase inhibitors. In simple terms, it targets the EGFR protein signal that can drive the growth of certain lung-cancer cells. By selectively blocking this signal, the medicine is used as part of a treatment plan directed by your oncologist. It does not work for lung cancers that do not carry the relevant EGFR mutation, which is why testing is required first.

Tagrisso vs generic Osimertinib

Generic osimertinib contains the identical active ingredient — osimertinib mesylate — at the same 40 mg and 80 mg strengths as branded Tagrisso. Generic medicines are produced by the same licensed pharmaceutical manufacturers and contain the same active pharmaceutical ingredient as the reference product. The principal difference patients notice is price: because generics do not carry the originator’s research-and-marketing overheads, they are typically priced far lower. Any switch between brand and generic should be discussed with your prescribing doctor.

Who Osimertinib is prescribed for

Osimertinib is prescribed for adults with non-small cell lung cancer whose tumours carry specific EGFR mutations, as confirmed by molecular testing. Your oncologist decides whether it is appropriate based on your diagnosis, mutation status, prior treatments, and overall health.

Osimertinib vs erlotinib and earlier EGFR inhibitors

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor. Earlier-generation medicines in the same family include erlotinib (the active ingredient in Tarceva) and gefitinib. The key practical difference is that osimertinib was designed to remain active against the T790M resistance mutation, which can develop after treatment with first-generation inhibitors. It is also designed to reach the central nervous system more effectively. Which medicine is appropriate depends entirely on your tumour’s mutation profile and treatment history — a decision only your oncologist can make after molecular testing. This page is for cost and access information, not for choosing a therapy.

Why Tagrisso is expensive — and why the generic costs less

Branded Tagrisso carries the cost of the original research, clinical trials, and global marketing that brought osimertinib to market, protected for years by patents. In countries where patents have expired or where generics are produced under licence, licensed pharmaceutical manufacturers can make the identical active ingredient without those overheads, which is why generic osimertinib is typically priced far lower. The medicine itself — osimertinib mesylate — is the same molecule at the same strength. For patients paying out of pocket, or in regions where the brand is not reimbursed, this price gap is often the difference between continuing or interrupting treatment, which is why so many people search for affordable generic options.

What to expect during treatment

Osimertinib is a long-term daily therapy that your oncology team monitors closely. Expect periodic scans to assess response, blood tests to watch blood counts and liver function, and occasional heart-rhythm (ECG) checks, since EGFR inhibitors can affect these. Many people take osimertinib for extended periods with manageable side effects, but you should report new breathlessness, cough, or fever promptly, as these can signal less common lung-related effects. Never stop or pause treatment on your own — continuity matters, and any change should be planned with your doctor.

Dosage & administration

Osimertinib is commonly prescribed as one 80 mg tablet once daily, taken at about the same time each day, with or without food. If a tablet cannot be swallowed whole, the patient leaflet describes how it may be dispersed in water. Your oncologist may adjust the dose or pause treatment based on tolerability and any side effects.

Dosage must be determined by a qualified healthcare provider. Do not change your dose or stop treatment without medical advice, and always follow the patient information leaflet supplied with your medicine.

Possible side effects

Reported side effects of osimertinib may include diarrhoea, rash or dry skin, changes to the nails, mouth sores, and tiredness. Less commonly, effects on the lungs, heart rhythm, or blood counts can occur, which is why your oncologist monitors you during treatment.

This is not a complete list. Read the patient information leaflet for full details and report any concerning or persistent symptoms to your healthcare provider promptly.

Osimertinib price comparison

Originator prices below are indicative and vary by country, dose, and insurance status. Generic pricing is shown on each product page. The aim of this comparison is to illustrate the typical cost gap that drives patients to seek licensed generics.

Available generic Osimertinib products

Browse in-stock generic Osimertinib below. Each product page lists strength, manufacturer, and current pricing.

How to order generic Osimertinib

1. Choose your strength and pack size on the product page.
2. Add to cart and proceed to checkout.
3. Upload a valid prescription from your healthcare provider.
4. Complete payment securely; your order ships in discreet packaging with tracking.

Shipping & delivery

We ship to 100+ countries with tracked, discreet packaging. Delivery typically takes 5–15 business days depending on destination and customs. Our team can provide tracking and customs documentation where applicable.

Is it legal to import Osimertinib for personal use?

Personal-import regulations differ from country to country. Many countries allow individuals to import a limited supply of prescription medicine for personal use when they hold a valid prescription. It is your responsibility to confirm the rules that apply where you live before ordering. If you are unsure, consult your healthcare provider or local regulator.

Safety information

Osimertinib is a prescription-only medicine used in certain types of EGFR-mutation-positive non-small cell lung cancer (NSCLC). As a third-generation EGFR tyrosine kinase inhibitor, it should only be used under the guidance of a qualified healthcare professional. Dosage must be determined by your provider. Tell your doctor about all medicines you take and any existing health conditions. Read the patient information leaflet supplied with your medicine for the full list of precautions, possible side effects, interactions, and storage instructions. Keep all medicines out of reach of children, and inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding.

Why order from OnlineMeds

• Genuine medicines sourced from licensed pharmaceutical manufacturers
• Discreet, tracked worldwide delivery to 100+ countries
• Simple prescription upload at checkout
• Pharmacist support before and after you order

Frequently asked questions

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before using any medication. Used as prescribed by a licensed medical professional.